Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
 
Register | Sign in
Home Page > Videos > DeNovix DS-11: Next Generation 1uL spectrophotometer for DNA, RNA & Protein
  Videos

Return

DeNovix DS-11: Next Generation 1uL spectrophotometer for DNA, RNA & Protein
DeNovix, Inc.

The patent pending DS-11 spectrophotometer rapidly quantifies 0.5 – 1.5 ul samples of nucleic acids and proteins. The stand-alone unit includes an Android™ based operating system that does not require a PC. The DS-11 meets or exceeds the performance specifications of the market leading microvolume spectrophotometer while saving space, time and money. Free one-week trials are available for US & UK* customers. DeNovix pays the shipping costs to and from your lab for evaluation. See website for details. The system features a glove compatible, 7” HD touch screen. The DS-11 includes Wi-Fi, USB, and Ethernet connectivity, allowing users to easily export data via email, a USB drive, or via an optional printer. Measurements are made using intuitive EasyApps® designed for the most common life science applications. Rapidly quantify DNA, ssDNA, RNA, purified proteins, labeled proteins, or obtain user defined spectrophotometric measurements using the pre-installed apps. The DS-11 is a full spectrum (190-840nm) UV-Vis spectrophotometer and measures the broadest concentration range of any microvolume spectrophotometer. Options include three color choices and an optional model that includes both microvolume and cuvette modes (DS-11+). With SmartPath® Technology, the DS-11 provides reliable 1uL sample results every time. The instrument's opto-mechanical components and proprietary algorithms together provide pathlength control and performance unmatched by any microvolume and spectrophotometer. Benefits of SmartPath Technology: » No recalibration time or expense » Measure proteins with confidence » Results in 4 seconds - no dilutions required » Broadest dynamic range: 0.04 - 500 AU (1 cm equivalent) Measurement range: 2.0 - 25,000 ng/µL dsDNA and 0.10 - 750 mg/ml BSA For more information about the DeNovix DS-11 Microvolume Spectrophotometer, or to locate distributors and representatives visit: http://www.denovix.com About DeNovix Inc.: DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company’s first product, the DS-11 Spectrophotometer, is the first stand-alone microvolume spectrophotometer that is controlled by a built-in Android™ operating system. The instrument, used for quantification of nucleic acids and proteins, features an easy to use brilliant touch screen interface, Wi-Fi and Ethernet connectivity, four-second measurement time; three color choices and two model choices. *UK trial offer not valid for Northern Ireland.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Link Between Viral Infection And Autoimmune Disease Found
Common viral infections can pave the way to autoimmune disease, Australian scientists have revealed in breakthrough research published internationally today.
Human Cancer Prognosis Is Related to Newly Identified Immune Cell
A rare population of tumor-associated “good” cells slows cancer.
Researchers Describe New Method for Cell Line Authentication
SNP profiling, an effective method to detect misidentification, contamination, and chromosomal abnormalities in mouse cell lines.
Peptide Mimics as a Drug Target for Ebola
University of Utah researchers create a tool to develop treatments for Ebola using Protein Technologies’s peptide synthesizer.
CDC Develops a New, Faster Lab Test for Enterovirus D68
Confirmed cases will appear to rise as agency accelerates specimen testing.
Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of ALL Patients Studied
University of Pennsylvania and Children's Hospital of Philadelphia studies reveal unprecedented results with investigational therapy made from patients' own immune cells.
New Lead for Potential Parkinson’s Treatment
Effects of high-risk Parkinson’s mutation are reversible.
Researchers Develop New Cells Meant to Form Blood Vessels
A technique to jump-start the body's systems for creating blood vessels for the treatment of peripheral artery disease.
New Test can Help Doctors Choose Best Treatment for Ovarian Cancer
ADNEX discriminate between benign and malignant tumours with a high level of accuracy.
Novel Mutations Discovered In Cats Provide Insight Into Human Eye Diseases
99 Lives Cat Genome Sequencing Initiative makes discoveries using Maverix analytic platform.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv